Navigation Links
BioMotiv Secures $21 million in Initial Funding
Date:9/5/2012

CLEVELAND, Sept. 5, 2012 /PRNewswire/ -- BioMotiv today announced that it has secured $21 million in financing from its founding investors, University Hospitals and the Harrington Family. 

"BioMotiv is a new model for accelerating breakthrough discoveries into medicines and aligning capital and collaborations to develop a portfolio of therapeutics," said Baiju R. Shah, Chief Executive Officer of BioMotiv.  "Through their commitment, University Hospitals and the Harrington family have once again demonstrated their dedication to solving a major national challenge that prevents promising discoveries from advancing to patient benefit."

"The challenge of translating discoveries into clinical development requires an innovative, next-generation business model," said Ron Harrington, a successful entrepreneur and recognized philanthropist. "BioMotiv's mission-aligned model and experienced team will enable it to efficiently and effectively manage a portfolio of early-stage drugs."

BioMotiv is the mission-driven, for-profit therapeutic accelerator affiliated with The Harrington Project for Discovery and Development, a $250 million initiative announced by University Hospitals this past February. "Our mission is 'To Heal. To Teach. To Discover.,'" said Achilles A. Demetriou, MD, PhD, Chief Operating Officer of University Hospitals.  "The project, supported by the generosity of the Harrington family, is a national initiative to advance the standard of care by creating structures that support physician-scientists in developing their insights into new therapies."

The initial capital will be used to launch operations and initiate the development of BioMotiv's technology portfolio which is being sourced from leading academic medical centers and industry sources from across the country.  The company plans to raise a total of $100 million in capital.

About The Harrington Project for Discovery and Development

The Harringt
'/>"/>

SOURCE BioMotiv
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMotiv Names New Chief Executive Officer
2. Delcath Systems, Inc. Secures $20 Million Credit Facility
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Benvenue Medical Secures $25 Million Series D Financing
5. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
6. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
7. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
10. Arthrosurface Hits a $100 Million Milestone
11. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., (NASDAQ: ... today that clinical data presented at the 2015 ... urine-based Precision Cancer Monitoring ℠ (PCM) platform ... of EGFR T790M mutations in metastatic ... of EGFR T790M Mutation in Urinary Circulating Tumor ...
(Date:4/17/2015)... 2015 Steven Rash , the CEO of ... operating subsidiary American Seed & Oil Company, presented the ... yesterday in New York City.  Mr. Rash,s presentation featured ... Seed & Oil Company has recently announced the ... Seed Foods , the EpiVape , and ...
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) has ... Pharma in 2014 - a Perspective of Mental Health ... offering. For the first time, in 2014, ... of the pharmaceutical industry held by patient groups with ... patient organisations representing all therapy areas. - ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... , , MINNEAPOLIS and ST. PAUL, Minn., Nov. 16 ... connected with friends, keeping up with school, and simply passing time ... More and more patients are relying on technology to help, from ... But when that technology fails, it can bring added stress to ...
... , WASHINGTON, Nov. 16 Despite ... market has increased approximately 15 percent in the past two ... Deloitte Center for Health Solutions. Retail clinic market growth, however, ... and will accelerate above 30 percent from 2013-2014, according to ...
Cached Medicine Technology:Children's Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In-Hospital Precinct 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 3Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 4
(Date:4/17/2015)... Texas (PRWEB) April 17, 2015 From the ... years ago, the Texas non-profit organization has empowered young people ... its effort to bring fresh water and the Gospel ... with Liberty University. Between March 17 and 27, students, faculty ... provide 7,000 Liberians with fresh water and the Good News ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed ... HR 1849 in congress on April 16, 2015 in ... patients with the genetic disease. , The bill, ... the first to create a federally led and financed ... hemorrhagic telangiectasia. This would effectively prevent premature death and ...
(Date:4/17/2015)... 2015 At the end of February ... the “Salute to the Oscars” in the Stardust Penthouse ... overlooking the impressive Los Angeles skyline. These events honoring ... Durkin, LA’s leading producer of sustainable product placement in ... world’s premier providers of eco-friendly and socially conscious products ...
(Date:4/17/2015)... April 17, 2015 Baptist Health and ... signed a partnership agreement designed to transform oncology care ... institutions have agreed to create a joint cancer program ... and translational research. Baptist MD Anderson Cancer Center is ... a single destination for highly coordinated, multidisciplinary cancer care ...
(Date:4/17/2015)... April 17, 2015 The American College of Traditional ... Free Application Day on April 29. The event will be held ... located at 555 DeHaro St. in San Francisco, CA. , The ... Check in at the DeHaro campus (room F), 11:10 a.m. ... campus, Noon – Light lunch with current students, faculty and staff, ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... have significantly cut down use of illicit drugs, but have ... ,Dr. Grant Mitchell, chief of psychiatry at Northern Westchester ... me. As we write more and more prescriptions for potentially ... don't have the same need to go out and procure ...
... that the people of India constitute more than ... been underrepresented in studies related //to genetic diseases. ... diseases associated with urban and western lifestyles have ... association studies of particular importance. ,In ...
... published online by Developmental Biology, members of Dr. John ... report the discovery// of a new protein within a ... male contraceptive drugs. ,“There’s considerable interest in ... Center for Research in Contraceptive and Reproductive Health. “To ...
... estimate of the repercussions of a potential flu pandemic showed ... the underprivileged nations, could pay// with their life. , ... infamous 1918 Spanish flu, which wiped out nearly 20 million ... of Public Health and the University of Queensland studied the ...
... with neuroblastoma tumors have been successfully treated with genetically ... activated a chemotherapy drug directly at// those sites, according ... their colleagues at City of Hope National Medical Center ... Canada). Neuroblastoma is a solid tumor that arises in ...
... mind set play a significant role in healing process, according ... ,During the experiment, pain was first induced in 40 ... to expect reduced pain after the application of a cream ... suggest : faith in a Doctor or a medicine leads ...
Cached Medicine News:Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2Health News:Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers 2Health News:Genetically Modified Cells Attack Tumors 2Health News:Genetically Modified Cells Attack Tumors 3Health News:Role Of Faith In Healing Process 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: